Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Arvelle Therapeutics Sweden filial
FL
Active
Org 5164122714
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2020
0 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Arvelle Therapeutics Sweden filial
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Former (5)
FA
Fräs Anna Kristina Andersson
Deputy Chief Executive Officer
Deputy Chief Executive Officer
2022 – 2022
MK
Marten Keuning 'e/v Pasman
Chief Executive Officer
Chief Executive Officer
2020 – 2022
ÅM
Åsa Marianne Magnusson
Deputy Chief Executive Officer
Deputy Chief Executive Officer
2021 – 2022
SC
Silvestro Camerini
Deputy Chief Executive Officer
Deputy Chief Executive Officer
2021 – 2022
SF
Serena Francesca Lina Zucchetta
Deputy Chief Executive Officer
Deputy Chief Executive Officer
2021 – 2022
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Arvelle Therapeutics Sweden filial
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
Riskpilot